Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
Danping Zhuang, Hui-fen Zhang, Genwen Hu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2116-2116
Open Access | Times Cited: 115
Copper-based nanomaterials for biomedical applications
Qichen Wei, Yue Pan, Zheng Zhang, et al.
Chemical Engineering Journal (2024) Vol. 483, pp. 149040-149040
Open Access | Times Cited: 9
Challenges and Material Innovations in Drug Delivery to Central Nervous System Tumors
Zhenyu Gong, Dairan Zhou, Dejun Wu, et al.
Biomaterials (2025) Vol. 319, pp. 123180-123180
Closed Access | Times Cited: 1
Lactoferrin Nanoparticle-Vanadium Complex: A Promising High-Efficiency Agent against Glioblastoma by Triggering Autophagy and Ferroptosis
Shuangshuang Gai, Qiwei Yan, Shan Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Alginate-Derivative Encapsulated Carbon Coated Manganese-Ferrite Nanodots for Multimodal Medical Imaging
Pemula Gowtham, Koyeli Girigoswami, Pragya Pallavi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2550-2550
Open Access | Times Cited: 35
Progress and Challenges in the Diagnosis and Treatment of Brain Cancer Using Nanotechnology
Yogita Ale, Nidhi Nainwal
Molecular Pharmaceutics (2023) Vol. 20, Iss. 10, pp. 4893-4921
Closed Access | Times Cited: 19
Emerging extracellular vesicle-based carriers for glioblastoma diagnosis and therapy
Jingjing Wang, Yue Liu, Fengbo Liu, et al.
Nanoscale (2023) Vol. 15, Iss. 26, pp. 10904-10938
Closed Access | Times Cited: 17
Canine glioblastoma-derived extracellular vesicles as precise carriers for glioblastoma imaging: Targeting across the blood-brain barrier
Alessandro Villa, Zemira De Mitri, Simona Vincenti, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116201-116201
Open Access | Times Cited: 5
Emerging Head and Neck Tumor Targeting Contrast Agents for the Purpose of CT, MRI, and Multimodal Diagnostic Imaging: A Molecular Review
Jonathan M. Neilio, Daniel Thomas Ginat
Diagnostics (2024) Vol. 14, Iss. 15, pp. 1666-1666
Open Access | Times Cited: 5
Advances of NIR Light Responsive Materials for Diagnosis and Treatment of Brain Diseases
Dongzhi Xue, Yinghui Wang, Hongjie Zhang
Advanced Optical Materials (2023) Vol. 11, Iss. 11
Closed Access | Times Cited: 13
Protease-Mediated T1 Contrast Enhancement of Multilayered Magneto-Gadolinium Nanostructures for Imaging and Magnetic Hyperthermia
Sahitya Kumar Avugadda, Nisarg Soni, Emille M. Rodrigues, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 6, pp. 6743-6755
Open Access | Times Cited: 4
Osteosarcoma-targeted Cu and Ce based oxide nanoplatform for NIR II fluorescence/magnetic resonance dual-mode imaging and ros cascade amplification along with immunotherapy
Mo Cheng, Qing‐Jie Kong, Qing Tian, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Utilization of nanomaterials in MRI contrast agents and their role in therapy guided by imaging
Wenjia Wang, Shufan Shang, Y. A. Wang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 4
Synergistic enhancement of low-dose radiation therapy via cuproptosis and metabolic reprogramming for radiosensitization in in situ hepatocellular carcinoma
Ni Shao, Yongqing Yang, Genwen Hu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Applications of magnetic nanohybrids for magnetic resonance imaging and nanobioimaging
Saleem Ullah, M. Atif, Rimsha Haqqi, et al.
Elsevier eBooks (2025), pp. 143-168
Closed Access
The role of manganese-based MRI contrast agents for cancer theranostics: Where do we stand in 2025?
Lingyan Zhang, Shubham Roy, Bing Guo
Theranostics (2025) Vol. 15, Iss. 9, pp. 4147-4174
Open Access
Enhanced detection of glioblastoma vasculature with superparamagnetic iron oxide nanoparticles and MRI
Phillip W. Janowicz, Thomas Boele, Richard Maschmeyer, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature
Yongqing Yang, Nianlan Cheng, Qiao Luo, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3663-3694
Open Access | Times Cited: 9
Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma
Zhen Wang, Xianglong Tang, Mengjie Zhao, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Metal-Organic Frameworks: Versatile Platforms for Biomedical Innovations
Cătălin Păun, Ludmila Motelică, Denisa Ficai, et al.
Materials (2023) Vol. 16, Iss. 18, pp. 6143-6143
Open Access | Times Cited: 9
Biomimetic Theranostic Agents with Superior NIR-II Photoacoustic and Magnetic Resonance Imaging Performance for Targeted Photothermal Therapy of Prostate Cancer
Ling Liu, Shangpo Yang, Ziliang Zheng, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1617-1617
Open Access | Times Cited: 8
Spatiotemporal Concurrent PARP Inhibitor Sensitization Based on Radiation‐Responsive Nanovesicles for Lung Cancer Chemoradiotherapy
Fei Kang, Meng Niu, Zijian Zhou, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 28
Closed Access | Times Cited: 2
Harnessing curcumin in a multifunctional biodegradable metal-organic framework (bio-MOF) for targeted colorectal cancer theranostics
Maryam Babaei, Amir Abrishami, Sonia Iranpour, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 2
NCDN is a Potential Biomarker and Therapeutic Target for Glioblastoma
Xiaokai Huang, Chengwu Xu, Haipeng Dai, et al.
Journal of Cancer (2024) Vol. 15, Iss. 4, pp. 1067-1076
Open Access | Times Cited: 1
A comparison study of dynamic [18F]Alfatide II imaging and [11C]MET in orthotopic rat models of glioblastoma
Yue Pan, Haodan Dang, Haoxi Zhou, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top